Divi's Laboratories Ltd. — Investor Relations & Filings
Divi's Laboratories Ltd. is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates, specializing in Contract Research and Manufacturing Services (CRAMS) for the global pharmaceutical industry. The company operates through two primary business segments: Generic APIs and Custom Synthesis of APIs and intermediates for discovery-marketed drugs. Its product portfolio includes a wide range of therapeutic areas, with significant market leadership in products such as Naproxen, Dextromethorphan, and Gabapentin. Additionally, the company produces nutraceutical ingredients, including a comprehensive range of carotenoids. Divi's maintains large-scale manufacturing facilities compliant with international regulatory standards, including the USFDA and EU GMP. The organization focuses on process chemistry and efficient large-scale production to support major global pharmaceutical companies in drug development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Appointment | 2025-11-07 | English | |
| Outcome of Board Meeting | 2025-11-07 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2025-10-29 | English | |
| Copy of Newspaper Publication | 2025-10-14 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2025-10-07 | English | |
| Trading Window | 2025-09-30 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 42397888 | Appointment | 2025-11-07 | English | ||
| 42398077 | Outcome of Board Meeting | 2025-11-07 | English | ||
| 42253245 | Analysts/Institutional Investor Meet/Con. Call Updates | 2025-10-29 | English | ||
| 42272601 | Copy of Newspaper Publication | 2025-10-14 | English | ||
| 42277552 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2025-10-07 | English | ||
| 42285730 | Trading Window | 2025-09-30 | English | ||
| 42318440 | Change in Management | 2025-09-05 | English | ||
| 42333602 | Copy of Newspaper Publication | 2025-08-30 | English | ||
| 42388277 | Analysts/Institutional Investor Meet/Con. Call Updates | 2025-08-12 | English | ||
| 42399981 | Shareholders meeting | 2025-08-11 | English | ||
| 42310235 | Copy of Newspaper Publication | 2025-08-07 | English | ||
| 42322573 | Analysts/Institutional Investor Meet/Con. Call Updates | 2025-08-06 | English | ||
| 42334003 | Updates | 2025-08-06 | English | ||
| 42334601 | Outcome of Board Meeting | 2025-08-06 | English | ||
| 42370515 | Analysts/Institutional Investor Meet/Con. Call Updates | 2025-07-28 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Divi's Laboratories Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61129/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61129 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61129 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61129 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61129}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Divi's Laboratories Ltd. (id: 61129)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.